Metin DEMİRKAYA, Halil SAĞLAM, Candan DEMİRÖZ-ABAKAY, Lütfi ÖZKAN, Oya KARADAĞ

Evaluation of late effects of postoperative radiotherapy in patients with medulloblastoma

We aimed to evaluate long-term toxicity in children with medulloblastomatreated with postoperative radiotherapy (RT).This study included 21 patients aged 4-16 who had been diagnosed withmedulloblastoma. All of the patients in the study received postoperativecraniospinal RT. Postoperative RT followed by chemotherapy was the treatmentprotocol. A total of 13 patients (62%) received chemotherapy concurrentlywith RT.Overall survival was 50 months (range, 1-169 months) and disease-freesurvival was 39 months (range, 4-171 months). In the data analysis, theheights of 11 patients (91.6%) were found to be below 50% on the heightcurve, and 8 (66.6%) patients had weights below 50% on the weight curve.Mean sitting height was 72.58±6.33 cm, and this was statistically correlatedwith parameters such as LH level (p=0.037), testosterone level (p=0.020),height (p=0.002), weight (p=0.033) and age at diagnosis (p=0.002).Radiation therapy for medulloblastoma seems to have a late toxic effect onlong-term survivors. With the improving survival rate of medulloblastomapatients, RT doses should be as low as possible without sacrificing efficacy.

PDF

___

1. Sirachainan N, Nuchprayoon I, Thanarattanakorn P, et al. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy. J Clin Neurosci 2011; 18: 515-519.
2. Bouffet E, Gentet JC, Doz F, et al. Metastatic medulloblastoma: the experience of the French Cooperative M7 Group. Eur J Cancer 1994; 30: 1478- 1483.
3. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006; 24: 4202-4208.
4. Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995; 25: 166-178.
5. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 2003; 21: 1581-1591.
6. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol 2005; 23: 4726-4734.
7. Kortmann RD, Kühl J, Timmermann B, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000; 46: 269-279.
8. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999; 17: 832-845.
9. Ribi K, Relly C, Landolt MA, Alber FD, Boltshauser E, Grotzer MA. Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics 2005; 36: 357-365.
10. Heikens J, Michiels EM, Behrendt H, Endert E, Bakker PJ, Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 1998; 34: 1592-1597.
11. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 1986; 108: 219-223.
12. Corrias A, Picco P, Einaudi S, et al. Growth hormone treatment in irradiated children with brain tumors. J Pediatr Endocrinol Metab 1997; 10: 41-49.
13. Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1997; 80: 798-804.
14. Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab 2001; 86: 5245-5251.
15. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998; 16: 1723-1728.
16. Bussières L, Souberbielle JC, Pinto G, Adan L, Noel M, Brauner R. The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol (Oxf) 2000; 52: 735-739.
17. Sklar C, Sarafoglou K, Whittam E. Efficacy of insulinlike growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 1993; 129: 511-515.
18. Tillmann V, Buckler JM, Kibirige MS, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 531-535.
19. Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf) 1998; 48: 777-783.
20. Clayton PE, Shalet SM. The evolution of spinal growth after irradiation. Clin Oncol 1991; 3: 220-222.
21. Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol 1997; 28: 348-354.
22. Xu W, Janss A, Moshang T. Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab 2003; 88: 4677-4681.
23. Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2002; 53: 543-547.
24. Ricardi U, Corrias A, Einaudi S, et al. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2001; 50: 1287-1294.
25. Corrias A, Einaudi S, Ricardi U, et al. Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols. J Endocrinol Invest 2001; 24: 387-392.